We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use www.guysandstthomasevents.co.uk, remember your settings and improve our services. We also use cookies set by other sites to help us deliver content from their services.
4th New Developments and Controversies in Thyroid Cancer 2026
This symposium will provide an update on the management of recurrent primarily differentiated thyroid cancer by focusing on the understanding of the latest evidence
This course is aim for the residents, consultants, allied health professionals in Otorhinolaryngology, Head and Neck Surgery, General and Endocrine Surgery, Endocrinology and Oncology who deal with thyroid cancer. The purpose is to address the basic principles of epidemiology, basic sciences diagnostics, treatment modalities, follow-up of thyroid cancer patients. The second day incorporating the New Developments and Controversies in Medullary Thyroid Cancer is more specifically dedicated for all those with an interest in the management of medullary thyroid cancer. The course is a multidisciplinary course and everyone involved in the management of thyroid cancer is welcomed.
The event is badged and supported by:
British Association of Head and Neck Oncologists
European Head and Neck Society (EHNS)
British Association of Endocrine and Thyroid Surgeons (BAETS)
British Thyroid Association (BTA)
Confederation of Otorhinolaryngology Head and Neck Surgery (CEORL-HNS)
ENT UK Head and Neck Society
Who should attend
This event is targeted to all members of the Thyroid Multidisciplinary teams treating thyroid cancer including qualified staff and trainees. These include Surgeons, Endocrinologists, Nuclear Physicians, Oncologists, Clinical Nurse Specialists, Speech and Language Therapists.
